Luke A. Pallansch

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

Roger G. Ptak, Philippe Gallay, Dirk Jochmans et al. · Antimicrobial Agents and Chemotherapy · 2008 · 113 citations · Full text

Immunology, Antiviral Drug, Synthetic Cyclosporine +16

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1

J O Ojwang, Robert W. Buckheit, Yves Pommier et al. · Antimicrobial Agents and Chemotherapy · 1995 · 104 citations · Full text

Hiv-1 Integrase, Potent Inhibitor, Immunology +22

SJ-3366, a Unique and Highly Potent Nonnucleoside Reverse Transcriptase Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1) That Also Inhibits HIV-2

Robert W. Buckheit, Karen Watson, Valerie Fliakas-Boltz et al. · Antimicrobial Agents and Chemotherapy · 2001 · 77 citations · Full text

Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide

Robert W. Buckheit, T L Kinjerski, Valerie Fliakas-Boltz et al. · Antimicrobial Agents and Chemotherapy · 1995 · 72 citations · Full text

Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells

Udayan Chatterji, Michael Bobardt, Robyn L. Stanfield et al. · Journal of Biological Chemistry · 2005 · 71 citations · Full text